Log In
BCIQ
Print this Print this
 

STP801

  Manage Alerts
Collapse Summary General Information
Company Sirnaomics Inc.
DescriptionShort interfering RNA (SiRNA) therapeutic
Molecular Target
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentDiscovery
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today